Track: Breast Cancer

Breast cancer session will
provide a comprehensive overview of the latest advancements in breast cancer
research, diagnosis, and treatment. We will discuss innovations in early
detection methods, including mammography, ultrasound, and emerging molecular
imaging technologies. Experts will explore the role of genetic testing and
personalized medicine in identifying at-risk individuals and tailoring
treatment plans to improve patient outcomes.
Invasive Ductal Carcinoma
(IDC):
Gain insight into the most common
type of breast cancer, Invasive Ductal Carcinoma (IDC). IDC sub-sessions
will cover its pathophysiology, diagnosis, staging, and the latest treatment
strategies, including surgery, chemotherapy, targeted therapy, and personalized
care approaches.
Invasive Lobular Carcinoma
(ILC):
Learn about Invasive Lobular
Carcinoma, the second most common type of breast cancer. This sub-session will
cover its unique characteristics, challenges in diagnosis, and recent
advancements in treatment options, emphasizing personalized approaches and
strategies for improved patient outcomes.
Ductal Carcinoma In Situ
(DCIS):
Gain insight into DCIS, a
non-invasive breast cancer that remains confined to the ducts. DCIS sub-session
will cover diagnosis, risk factors, and treatment options, emphasizing the
importance of early detection and approaches to prevent progression to invasive
cancer.
Inflammatory Breast Cancer
(IBC):
Gain insights into the unique
characteristics, diagnosis, and challenges of inflammatory breast cancer. Inflammatory
Breast Cancer sub-session will explore recent research, advancements in
early detection, and innovative treatment approaches to improve outcomes and
address the aggressive nature of IBC.
Triple-Negative Breast Cancer
(TNBC):
Explore the unique challenges of
diagnosing and treating triple-negative breast cancer, known for its aggressive
nature and lack of targeted therapies. TNBC sub-session will cover
recent advances in treatment strategies, clinical trials, and personalized
approaches to improve patient outcomes.
HER2-Positive Breast Cancer:
Explore the significance of
HER2-positive breast cancer, its impact on prognosis, and advancements in
targeted therapies. This sub-session will cover current treatment strategies,
including HER2-targeted drugs, resistance mechanisms, and ongoing research
aimed at improving patient outcomes.
Scientific Highlights
- Field of Cancer
- Gynecologic cancer
- Covid and Its Impact on Cancer
- Cancer Cell Biology & Genetics
- Cancer Imaging Techniques
- Diagnosis and Treatment of Cancer
- Breast Cancer
- Head and Neck Cancer
- Pediatric Cancer
- Oncology Nursing and Care
- Advances In Cancer Research And Treatment
- Neuro-Oncology
- Cardio-Oncology